Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas

Open Access

Peer-reviewed

Research Article

Till Plönes,

Affiliation Department of Thoracic Surgery, University Medical Center Freiburg, Freiburg, Germany
⨯
Alexander Krohn,

Affiliation Department of Oncology and Haematology, University Medical Center Freiburg, Freiburg, Germany
⨯
Meike Burger,

Affiliation Department of Oncology and Haematology, University Medical Center Freiburg, Freiburg, Germany
⨯
Hendrik Veelken,

Affiliation Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands
⨯
Bernward Passlick,

Affiliation Department of Thoracic Surgery, University Medical Center Freiburg, Freiburg, Germany
⨯
Joachim Müller-Quernheim,

Affiliation Department of Pneumology, University Medical Center Freiburg, Freiburg, Germany
⨯
Gernot Zissel

* E-mail: gernot.zissel@uniklinik-freiburg.de

Affiliation Department of Pneumology, University Medical Center Freiburg, Freiburg, Germany
⨯

Reader Comments (0)

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Adenocarcinoma
Is the Subject Area "Adenocarcinoma" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.
Gastric cancer
Is the Subject Area "Gastric cancer" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Carcinoma
Is the Subject Area "Carcinoma" applicable to this article?

Thanks for your feedback.
Adenocarcinoma of the lung
Is the Subject Area "Adenocarcinoma of the lung" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.